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Significance of Pathophysiology
The Genetic Influences on Opiate Addiction
Anne Sielschott, RN, BSN
Introduction
The effects of addiction and the present opioid crisis can not only be felt at the individual level of 
the addict but throughout all aspects of society.  From the infant born addicted to heroin, to the 
family members begging their loved ones to make a change, to the medical personnel with the 
responsibility of caring for those with drug seeking or violent behavior needing their next fix, the 
drug problem in America is one that can no longer be ignored.  The number of unintentional drug 
overdoses in Ohio has grown from 411 in 2000 to a staggering 3050 in 2015, currently averaging 8 
deaths per day in Ohio alone (Ohio Department of Health [ODH], 2017).  
It is the responsibility of medical personnel to not only be aware of the statistics and trends 
regarding this crisis, but to be knowledgeable and up to date on the current research regarding 
what makes an individual an addict.  What differences exist, for example, between Jimmy and Sally 
following knee surgery that has Jimmy returning to the emergency department with drug seeking 
behavior while Sally’s bottle sits half full on the shelf.  While not all aspects of the pathophysiology 
behind the genetic influences of addiction are understood, much research is being completed 
searching for these answers.  New models have also been developed that aid the provider in the 
accurate diagnosis of addiction and its associated behaviors (Belin-Rauscent, Fouyssac, Bonci, & 
Belin, 2016).  These models will aid the provider in the recognition of the problem and the 
development of a treatment plan
Signs and Symptoms
References
• loss of ability to control or stop 
use
• trouble meeting personal, social, 
and work obligations
• legal/financial/marital 
problems
• drug seeking behaviors, 
spending long amounts of time 
to obtain opiates
• tolerance, requiring larger 
doses for desired effect
• withdrawal symptoms with 
reduced or discontinued use
• constipation
• respiratory depression
• nausea/vomiting
• slurred speech
• confusion, delayed responses
• itching or flushed skin
• euphoria
• continual use despite negative 
physical or psychological effects
• stupor, coma, death
• anxiety and depression
• alienation and loss of friends 
and family relationships
• borrowing of money, selling 
possessions
(National Institute on Drug Abuse, 
n.d.)
The treatment of opiate addiction is a life-long battle with frequent relapses and high 
morbidity and mortality rates.  Due to these poor demographics, the efforts of containing 
the opiate crisis are focused on preventing further addiction.  Medical providers must be 
educated on the risks and benefits of prescribing opiates.  It is essential for prescribers to 
be up to date on the current recommendations and guidelines regarding opiate use and to 
only prescribe opiates to those that meet these guidelines.  Being aware of the genetic 
predispositions of various ethnicities or recognizing the signs and symptoms of behaviors 
highly associated with various genetic alterations and addiction can aid the provider in 
decision making.  A thorough physical and psychiatric exam and family history should be 
obtained on every patient prior to prescribing opiates to adequately assess the patient 
(Kolodny et al., 2015).  
Education is also key as it has been noted that more than 75% of those who abuse 
prescription pain medications originally obtained the medication from a friend or family 
member (Center for Disease Control [CDC], 2011).  Proper education regarding the risks 
associated with giving others these medications, especially to adolescents, is critical at 
preventing an addiction problem.  Those who use prescription pain medications that were 
not prescribed to them are four to nine times more likely to abuse heroin (Martins et al., 
2016).
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Nursing Implications
Opiate addiction is a nationwide problem felt by the entire 
population.  The State of Ohio has taken great steps towards 
containing the crisis.  Prescribing guidelines have been 
established by the Governor’s Cabinet Opiate Action Team 
(GCOAT) that address both acute and chronic pain control.  
Educational programs targeting the school age population have 
also been developed (ODH, 2017).  While not all is known 
about the genetic influences surrounding addition, a thorough 
understanding of the current knowledge and literature by 
healthcare providers, combined with the actions of the state 
and educational systems, has the potential to not only better 
treat and rehabilitate those with an opiate addiction but to 
prevent addiction before it happens.  
Conclusion
Opioids work by binding to opioid receptors throughout the nervous and immune systems. 
Four major types of receptors have been identified and include mu (μ), kappa (κ), delta (δ) and 
OFQ/N receptors.  These receptors are the binding sites for endogenous peptides, specifically 
enkephalins, dynorphins and endorphins.  These regulate many of the important functions of the 
body including pain, stress, temperature, respiratory drive, the endocrine system, 
gastrointestinal motility, mood, and motivation.  The most common opiates that are abused are 
mu agonists.  Mu receptors, when stimulated, are responsible for the “high” felt with opiate use, 
feelings of euphoria, and a decrease in anxiety (Dixon et al., 2017).    
The OPRM1, OPRD1, and OPRK1 genes fall into the opioid receptor category and code for their 
coordinating μ, δ, and κ receptors.  Genetic variations in these receptors have been studied 
across various ethnicities.  These studies have found links between these genetic variants and 
higher risks of developing addictions and dependence (Mistry, Bawor, Desai, Marsh, & Samaan, 
2014).
The opioid receptor mu 1 (OPRM1) gene encodes for the µ-opioid receptor, which is the 
primary site of action for most of the commonly abused opioids. A polymorphism of the OPRM1 
gene results in the replacement of asparagine residue with aspartic acid.  This results in the 
118G allele.  Increased sensitivity to pain and a decreased response to opioid treatment are 
associated with this genetic variation.  Studies of those with this variant have shown that 
participants with the 118G allele request higher doses of opiates for treatment of pain (Kreek et 
al., 2012).   
Dopamine is a powerful neurotransmitter, responsible for the positive rewards seen with 
things such as finishing a full meal, sexual encounters, and receiving an award.  The use of 
opiates creates a large amount of dopamine to be released into the “rewards center” of the brain, 
the nucleus accumbens, providing the “high” that is sought by addicts.  The drug type, amount, 
and route of administration have an effect on the amount of dopamine that is released, up to ten 
times the normal amount seen with pleasurable experiences, thereby causing the user to seek 
higher doses and better quality substances (Harvard Medical School, 2012).
Dopamine release and dopaminergic receptor expression is thought to have an association with 
impulsive and novelty-seeking behavior.  Genetic polymorphisms of the D2, D3, and D4 
dopamine receptor genes have been targets of recent studies linked to opioid addiction.  The 
DRD2 rs1800497 allele has been found to be higher in those with addition.  The identification of 
this allele helps predict the success of methadone treatment for opiate addiction.  Genetic 
polymorphisms of the DRD3 and DRD4 genes have been associated with an increase in sensation 
seeking and novelty seeking behaviors respectively as commonly seen in addicts (Mistry et al., 
2014).  
cAMP response element binding protein (CREB) and delta FBJ murine osteosarcoma viral 
oncogene homolog B (ΔFosB) are two transcription factors that have been gaining interest in the 
ongoing battle against addiction.   CREB is activated in the nucleus accumbens by opiates where 
it acts to reduce the rewarding behavior seen with drug use.  CREB increases the drive for 
seeking opiates through a negative feedback system.  This occurs by reducing the addict’s 
sensitivity to the rewards of the drug and enhances the negative experiences observed with the 
discontinuation of opiates. Target genes for CREB have been identified and are associated with 
the opioid peptide dynorphin.  Dynorphin impairs reward by suppressing the transmission of 
dopamine to the nucleus accumbens.  Addicts then seek larger, stronger doses of the drug to 
overcome the tolerance that has developed (Nestler, 2013). 
In contrast to CREB, ΔFosB promotes drug use through positive reinforcement where users 
see an increase in sensitivity to the drug and the positive rewards of drug use.  ΔFosB is encoded 
by the FOSB gene on human chromosome 19. The Fos family of transcription factors are 
activated during drug use and typically return to baseline levels within twelve hours.  ΔFosB, 
however, is unusually stabile and accumulates during repeated drug use. (Nestler, 2013).  ΔFosB
heterodimerizes with Jun family proteins and translocates to the cell’s nucleus where they bind 
to activator protein-1, causing gene expression.  This expression, resulting in cellular and 
molecular changes, results in the emergence of the phenotypical changes observed in the addict.  
With short term use of opiates, the activation of ΔFosB returns to baseline quickly.  With chronic 
use, however, the effects of ΔFosB can be detected months later, even after discontinuation of 
use.  This is thought to account for the relapses that occur during treatment and rehabilitation 
(Ruffle, 2014).  
Underlying Pathophysiology
It is thought that genetic influences account for 40-60% 
of one’s vulnerability to addiction.  These, combined with 
environmental influences including social, familial, work, 
and financial factors, help to determine the likelihood of 
addiction (National Institute on Drug Abuse, 2014).  Having 
a strong knowledge of the genetic factors associated with 
an increased likelihood of addition can help the provider in 
decision making regarding treatment options. By 
identifying the genetic alterations and the effects they have 
on an individual, providers have the opportunity to provide 
individualized care targeted at those most susceptible to 
addiction (Levran, Yuferov, & Kreek, 2012).   
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